Beth C. Seidenberg, Director at Vera Therapeutics, Inc. (VERA), bought 46,856 shares at $7.24 ($339K) on 2023-03-02, disclosed to the SEC on 2023-03-03.
Open-market purchase of $339k VERA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.25 | 100 | $725 | 0.2% |
| 2 | $7.24 | 23,378 | $169K | 49.9% |
| 3 | $7.24 | 23,378 | $169K | 49.9% |
| Total | $7.24 avg | 46,856 | $339K | 100% |
| Filing → |
| VERA | SELL | 2024-09-20 | $1.3M | — | Filing → |
| SGMT | BUY | 2023-07-20 | $750K | — | Filing → |
| SLRN | BUY | 2023-05-11 | $23.6M | — | Filing → |